Business

Eli Lilly’s second-quarter earnings report has stunned investors and analysts alike with its impressive performance. The pharmaceutical company reported earnings and revenue that far exceeded expectations, prompting a significant increase in its full-year revenue outlook. This exceptional growth was largely driven by the soaring sales of its blockbuster diabetes drug, Mounjaro, and weight loss injection,
0 Comments
In recent years, Disney’s media business has been a topic of concern among investors. With the rise of streaming services, traditional pay-TV facing challenges, and box office disappointments, the company’s theme parks and resorts have been the saving grace. However, the narrative seems to be shifting, as Disney’s combined streaming services, including Disney+, Hulu, and
0 Comments
Yum Brands recently reported a mixed quarter in which both Pizza Hut and KFC experienced declining same-store sales. Yum CEO David Gibbs attributed these challenges to the impact of the Middle East conflict and a more cost-conscious consumer base. These factors have created headwinds for the company, affecting its overall sales performance. Financial Performance Yum
0 Comments
Jeff Bezos, the founder of Amazon, has been making waves with his recent investments in artificial intelligence (AI). While his big-ticket purchases, such as a $165 million estate in Los Angeles and a $177 million property in Miami, have been grabbing headlines, it is his foray into AI through his family office, Bezos Expeditions, that
0 Comments
Delta Air Lines CEO Ed Bastian recently extended a token of appreciation to employees by offering them two free travel passes following the major disruptions caused by a botched CrowdStrike software update. The airline faced significant challenges in recovering from the disruptions, which led to the cancellation of more than 5,000 flights between July 19
0 Comments
After facing shortages in recent months, all doses of Eli Lilly’s popular weight loss injection Zepbound and diabetes drug Mounjaro are now fully available in the United States. The U.S. Food and Drug Administration recently updated its drug shortage database to reflect the increased availability of these medications, providing relief to patients who have been
0 Comments